Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2TSL71
Wed, 16.03.2022
SYNLAB AG
SYNLAB achieves record results in 2021 and exceeds all targets set at the IPO
Revenue reaching €3.76 billion (+€760 million vs. IPO guidance)
Consistent execution of underlying organic growth strategy with 9.6% non-COVID 19[1] organic revenue growth
Leadership in COVID-19 response with 35+ million PCR and non-PCR tests performed in 2021
Adjuste [ … ]
Fri, 11.03.2022
SYNLAB AG
SYNLAB joins the United Nations Global Compact initiative - the world's largest corporate sustainability initiative
SYNLAB joins the United Nations Global Compact initiative, demonstrating its commitment to taking responsible business actions and promoting well-being for all
SYNLAB, Europe's leading medical diagnostic services provider, is pleased [ … ]
Fri, 07.01.2022
SYNLAB AG
- Sistemas Genómicos' strong expertise in genetics - including bioinformatics, sequencing, molecular biology, and molecular genetics - will strategically complement SYNLAB's already leading genetics service offering and expand SYNLAB's leadership in specialty testing in Europe
- The integration of more than 100 highly-qualified professionals with e [ … ]
Wed, 10.11.2021
SYNLAB AG
- Strong revenue growth delivered since the beginning of the year
- +20% revenue growth in Q3 2021
- +64% in 9M 2021
- +3.5% underlying growth in 9M 2021 driven by For You initiatives
- Profitability uplift driven by volume leverage
- Q3 2021 margin remained elevated post H1 2021 peak
- 32.8% adjusted EBITDA margin in 9M 2021
- Extra cash [ … ]
Tue, 02.11.2021
SYNLAB AG
Significantly increased presence in Mexico: 100+ diagnostic service points and 1,700 employees
A platform to further expand presence in Mexico and Latin America
SYNLAB, Europe's leading medical diagnostics services provider, with a presence in 5 Latin American countries, closes the acquisition of Laboratorio Médico Polanco and Laboratorio Clinicos [ … ]
Mon, 04.10.2021
SYNLAB AG
SYNLAB AG
Moosacher Straße 88
80809 Munich
GermanyFeedtrail
5540 Centerview Drive, Suite 411
Raleigh, NC 27606
United States
Munich / Raleigh, NC (USA), 4 October 2021
SYNLAB expands partnership with Feedtrail to gain real-time patient and customer feedback
SYNLAB rolls-out Feedtrail XM platform across more than 2,000 sites in 36 countries t [ … ]
Thu, 12.08.2021
SYNLAB AG
- Revenue almost double for the second straight quarter: +96% growth in Q2'21
- Sustained strong SARS-CoV-2 testing volumes, 7.5 million PCR tests carried out
- Underlying organic growth[1] acceleration at +11.7%, lifted by UK hospital outsourcing contract
- H1'21 revenue of EUR 1,923 million, above expectations
- H1'21 adjusted EBITDA of EU [ … ]
Wed, 11.08.2021
SYNLAB AG
SYNLAB AG
Moosacher Straße 88
80809 Munich
GermanyIATA
33 Route de l'Aéroport
Geneva 1215
Switzerland
SYNLAB and IATA partner to facilitate safe and easy travelling
SYNLAB to securely share certified COVID-19 test results with passengers directly through IATA Travel Pass, providing reliable digital proof on health status as international travel [ … ]
Mon, 09.08.2021
SYNLAB AG
SYNLAB AG
Moosacher Straße 88
80809 Munich
Germany
German COVAG Study proves significant inaccuracy of rapid antigen tests in detecting SARS-CoV-2 variants and when applied to medium to low viral loads
The COVID-19 Antigen Study (COVAG Study), conducted by SYNLAB, the Universities of Heidelberg and Graz, and a large COVID-19 test centre in Stuttg [ … ]
Mon, 02.08.2021
SYNLAB AG
SYNLAB will acquire Laboratorio Médico Polanco and Laboratorio Clinicos de Puebla (LMP & LCR), a network of over 100 diagnostic service points in Mexico
By integrating LMP & LCR into the international SYNLAB laboratory network, SYNLAB will strengthen its strategic position in the region
SYNLAB will be ideally structured and positioned for [ … ]